Navigation Links
Prism and Medical College of Wisconsin investigators receive $1.6 million NIH grant to develop advanced medical imaging tools
Date:11/16/2009

Prism Clinical Imaging, Inc., in collaboration with investigators at The Medical College of Wisconsin in Milwaukee, has received a $1.6 million, three-year grant from the National Institutes of Health (NIH) to develop and clinically validate advanced medical imaging software that aids the diagnosis and treatment of patients with brain cancer.

"This project will allow us to refine and validate new methods for mapping brain function with MRI and for displaying the results in an intuitive format that greatly simplifies interpretation by the physician," said Edgar DeYoe, Ph.D., principal investigator, professor of radiology at the Medical College, and a co-founder of the company.

"Through Prism, we have developed software that gives physicians anatomical, functional and physiological image sequences in a single integrated view referred to as a "stack", similar to playing cards in a deck. We've also created a new display, a Functional Field Map, that instantly shows what the brain images mean for the patient's vision and movement abilities. This allows surgeons to identify and avoid areas of the brain that may be essential for movement, vision, and other functions, thereby permitting removal of as much of a tumor as possible without impairing a patient's brain function."

This multi-institutional grant includes researchers at Cleveland Clinic and Radiology Associates of Sacramento. At present, the new software is used primarily by research and academic institutions such as Froedtert Hospital, a major teaching affiliate of the Medical College of Wisconsin. Together the three sites hope to recruit 50 patients per year to the study.

Earlier studies have shown advantages of the functional field map for clinical use and commercialization. By further validating its potential in a controlled patient study, it will serve as a powerful tool to aid diagnosis, treatment planning, and follow-up assessment for virtually any brain pathology, especially cancer. The NIH grant will fund advanced development of this imaging technology in a program designed to promote commercial application of promising healthcare technologies. Prism is participating in the program in the effort to further develop its imaging technology and move it from research institutions like Froedtert and the Medical College into hospitals and clinics worldwide. Moving the technology into wider application at mainstream hospitals and clinics across the country will give a greater number of patients access to a technology that could significantly improve the outcomes of their cancer treatment.

"This type of technology is revolutionizing the treatment of brain cancer patients," said John Ulmer, M.D., associate professor of radiology. "Since it was developed here at the Medical College and Froedtert, we have surgeons and radiologists with extensive experience using this technology. Clinical data accumulated over the past three years shows that patients undergoing brain tumor surgery at Froedtert have a significantly better chance of avoiding neurological side effects than the national average." Ulmer is also a co-founder of Prism.

The grant was funded through the Small Business Technology Transfer (STTR) program at the NIH. The STTR program is intended to stimulate partnerships between innovative small business concerns and non-profit research institutions through federally funded research and development. "This NIH program is crucial for translating new technologies from laboratory curiosities into practical products that can be used routinely by doctors. It also is a real shot in the arm for small high-tech companies, especially in the current economic environment," said Dr. DeYoe.

"Development of advanced medical imaging technology is a high-tech specialty for academic and industrial groups in southeastern Wisconsin," said Paul Schmelzer, Prism chief executive officer. "This area has become an incubator for this type of advanced technology because of the concentration of scientific and business expertise in medical imaging in the greater Milwaukee area. "Building on this expertise, Froedtert Hospital and The Medical College of Wisconsin have become a primary focus for the development and dissemination of advanced healthcare options for residents of Milwaukee and the upper Midwest," Schmelzer added.


'/>"/>

Contact: Toranj Marphetia
toranj@mcw.edu
414-955-4700
Medical College of Wisconsin
Source:Eurekalert  

Related medicine news :

1. Samplify Systems Announces Next Generation Signal-Compression Technology, Prism 3.0
2. Improving the science of systematic reviews: Introducing the PRISMA statement
3. Prism Pharmaceuticals Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology
4. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
5. Prism Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
6. Prism Pharmaceuticals Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia
7. Prism glasses expand the view for patients with hemianopia
8. New Empire BlueCross BlueShield Prism Plans Offer Better Choice and Affordability for New York Small Group Market
9. Prism Pharmaceuticals Appoints Maurits Geerlings Vice President of Business Development
10. Healthcare Trust of America, Inc. Executes Agreement to Acquire a 62,000 SF Medical Office Building Located in Baltimore, Maryland
11. Cantel Medical To Join S&P SmallCap 600 Index
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Prism and Medical College of Wisconsin investigators receive $1.6 million NIH grant to develop advanced medical imaging tools
(Date:4/28/2017)... CA (PRWEB) , ... April 28, 2017 , ... ... pleased to announce the integration of Microsoft(R) Word(TM) Online(TM), which enables sleep physicians ... experience, since it streamlines the reporting process and provides a familiar interface that ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Horizon Blue Cross ... the company’s credit rating of “A” and its outlook as “stable.” At the same ... reserves, which have fallen in recent years, dip below “capital adequacy” thresholds required for ...
(Date:4/28/2017)... York, NY (PRWEB) , ... April 28, 2017 ... ... Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast U.S. ... recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically proven ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... Replace tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent ... rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... the "Global Biosimilar Pipeline and Market Prospects: Addressing ... report to their offering. ... "Global Biosimilar Pipeline and Market ... by Design" provides an in-depth assessment of the current ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology: